Health TrialsbyHealthPanel

Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors

ConditionIntracerebral Haemorrhage (ICH)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-70
SponsorSohag University

About this trial

The aim of this study is to assess the safety and efficacy of surgical evacuation of spontaneous intracerebral hemorrhage.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

• Patients with radiological findings of ICH.

Age group 20-70 years.

Disqualifiers

• Traumatic ICH or ruptured aneurysm or AVM or brain tumor.

Postoperative cranial surgery ICH.

Secondary hydrocephalus.

Patients with other comorbidities e.g., Liver cell failure and renal cell failure.

Trial design

Design model

Single group

Treatments tested in this trial

  • Surgical Evacuation of Intracerebral Hemorrhage

    Procedure/Surgery

    Surgical Evacuation of Intracerebral Hemorrhage

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Surgical evacuation of Intracerebral hemorrhageOther 1 intervention

Trial outcomes

Primary outcomes

1

Morbidity after surgical evacuation of Intracerebral hematoma

Complications within first month

Time frame
1 month
2

Mortality after surgical evacuation of Intracerebral hematoma

Death of patient within first month

Time frame
1 month

Secondary outcomes

1

Morbidity after surgical evacuation of Intracerebral hematoma

Complications from end of 1st month to end of 3rd month

Time frame
3 months
2

Mortality after surgical evacuation of Intracerebral hematoma

Death of patient

Time frame
3 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov
Apply now